Lisa Lohmann
Overview
Explore the profile of Lisa Lohmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
76
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gross C, Schulte-Mecklenbeck A, Steinberg O, Wirth T, Lauks S, Bittner S, et al.
Sci Transl Med
. 2024 Mar;
16(740):eade8560.
PMID: 38536936
One of the biggest challenges in managing multiple sclerosis is the heterogeneity of clinical manifestations and progression trajectories. It still remains to be elucidated whether this heterogeneity is reflected by...
2.
Duchow A, Bellmann-Strobl J, Friede T, Aktas O, Angstwurm K, Ayzenberg I, et al.
Ann Neurol
. 2023 Dec;
95(4):720-732.
PMID: 38086777
Objective: To investigate accumulation of disability in neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein-antibody-associated disease (MOGAD) in a changing treatment landscape. We aimed to identify risk factors for...
3.
Lohmann L, Glaser F, Moddel G, Lunemann J, Wiendl H, Klotz L
BMC Neurol
. 2022 May;
22(1):185.
PMID: 35585528
Background: Since the beginning of the COVID-19 pandemic and development of new vaccines, the issue of post-vaccination exacerbation or manifestation of demyelinating central nervous system (CNS) disorders has gained increasing...
4.
Trumpelmann S, Schulte-Mecklenbeck A, Steinberg O, Wirth T, Fobker M, Lohmann L, et al.
Clin Transl Sci
. 2022 Feb;
15(7):1606-1612.
PMID: 35213793
The impact of distinct disease-modifying therapies (DMTs) on severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) vaccination efficacy in patients with multiple sclerosis (MS) is still enigmatic. In this prospective comparative study,...
5.
Eschborn M, Pawlitzki M, Wirth T, Nelke C, Pfeuffer S, Schulte-Mecklenbeck A, et al.
Neurol Neuroimmunol Neuroinflamm
. 2021 Oct;
8(6).
PMID: 34667129
Background And Objectives: In MS, an age-related decline in disease activity and a decreased efficacy of disease-modifying treatment have been linked to immunosenescence, a state of cellular dysfunction associated with...
6.
Lohmann L, Klotz L, Wiendl H
Fortschr Neurol Psychiatr
. 2021 Oct;
89(10):516-530.
PMID: 34666391
The achievements of the last 15 years have essentially shaped the diagnostic methods and therapy of Neuromyelitis optica spectrum disorders (NMOSD): from discovery of aquaporin 4 antibodies and further development...
7.
Gross C, Schulte-Mecklenbeck A, Madireddy L, Pawlitzki M, Strippel C, Rauber S, et al.
Brain
. 2021 Apr;
144(9):2625-2634.
PMID: 33848319
Although CSF analysis routinely enables the diagnosis of neurological diseases, it is mainly used for the gross distinction between infectious, autoimmune inflammatory, and degenerative disorders of the CNS. To investigate,...
8.
Lohmann L, Lammerskitten A, Korsen M, Dodel R, Gaul C, Hamer H, et al.
Eur J Neurol
. 2021 Feb;
28(5):1446-1452.
PMID: 33539600
Background And Purpose: To provide an overview on the status of clinical research in neurology in Germany. Methods: German university hospitals, nonuniversity hospitals, and neurological medical practices were surveyed regarding...
9.
Heming M, Lohmann L, Schulte-Mecklenbeck A, Brix T, Gross C, Wiendl H, et al.
J Neuroimmunol
. 2020 Feb;
341:577171.
PMID: 32007787
Distinguishing neurosarcoidosis (NS) from multiple sclerosis (MS) remains challenging and available parameters lack discriminatory power. Comprehensive flow cytometry data of blood and CSF leukocytes of patients with NS (n = ...
10.
Obergassel J, Lohmann L, Meuth S, Wiendl H, Grauer O, Nelke C
Prion
. 2019 Dec;
14(1):24-28.
PMID: 31880189
Sporadic Creutzfeldt-Jakob disease is the predominant type of human prion disease. While routine diagnostic in phenotypic cases has advanced considerably, the clinical heterogeneity and rarity of subtypes continue to constitute...